Cytosorbents Corporation
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY1999 | -10,695.3% | -10,695.3% | — |
| FY2000 | -57.4% | -57.4% | — |
| FY2001 | -660.9% | -660.9% | — |
| FY2002 | 271.4% | 271.4% | — |
| FY2003 | 153.8% | 153.8% | — |
| FY2004 | 15.7% | 15.7% | — |
| FY2005 | 37.6% | 37.6% | — |
| FY2006 | -3,246.5% | -3,246.5% | — |
| FY2007 | 3,212.7% | 3,212.7% | — |
| FY2008 | 90.2% | 90.2% | — |
| FY2009 | 47.7% | 47.7% | — |
| FY2010 | 36.1% | 36.1% | -160.5% |
| FY2011 | 54.3% | 54.3% | -258.3% |
| FY2012 | 31.5% | 31.5% | -109.7% |
| FY2013 | 32.8% | 32.8% | -115.6% |
| FY2014 | -134.2% | -134.2% | -110.1% |
| FY2015 | -96.2% | -96.2% | -84.2% |
| FY2016 | -879.5% | -217.2% | -121.3% |
| FY2017 | -82.4% | -52.1% | -35.1% |
| FY2018 | -101.6% | -65.7% | -50.3% |
| FY2019 | -563.6% | -114.7% | -70.4% |
| FY2020 | -9.9% | -9.9% | -8.7% |
| FY2021 | -39.2% | -39.2% | -27.4% |
| FY2022 | -92.8% | -81.3% | -51.9% |
| FY2023 | -124.6% | -112.4% | -55.2% |
| FY2024 | -186.5% | -82.5% | -43.7% |
| FY2025 | -138.9% | -36.3% | -18.6% |